Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals
Financial Results:
Tatva Chintan Pharma Chem Ltd reported Revenues for Q1FY24 of ₹114.36 Crores up from ₹88.40 Crore year on year, a rise of 29.37%.
Total Expenses for Q1FY24 of ₹101.96 Crores up from ₹76.58 Crores year on year, a rise of 33.14%.
Consolidated Net Profit of ₹9.50 Crores down 3.06% from ₹9.80 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.29, down 2.94% from ₹4.42 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.